Hypercholesterolemia in patients undergoing coronary bypass surgery: are they aware, under treatment, and under control?
Hypercholesterolemia is an important determinant of progressive atherosclerosis in both vein grafts and native vessels after coronary artery bypass surgery. We demonstrated that nearly half of all patients admitted for coronary bypass have elevated cholesterol levels before surgery. Of these, half are unaware of the elevations in cholesterol level, and few are undergoing any treatment. The results suggest that lipids should be measured before coronary bypass surgery to optimize postoperative risk reduction education.